Biomunex Pharmaceuticals Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Later Stage VC
- Investors
-
6
Biomunex Pharmaceuticals General Information
Description
Developer of immunotherapies designed to deliver therapeutics in the area of oncology. The company's immunotherapies offer to develop drug candidates with high anti-tumor potential, superior manufacturability, and optimal drug-like properties, enabling biotechnology companies to format antibodies from any pair of monospecific monoclonal antibodies as building blocks in a timely and cost-effective manner.
Contact Information
Website
www.biomunex.comCorporate Office
- 101 / 103 boulevard Murat
- 75016 Paris
- France
Corporate Office
- 101 / 103 boulevard Murat
- 75016 Paris
- France
Biomunex Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Oct-2025 | Completed | Generating Revenue | |||
| 7. Grant | 03-Nov-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 16-Feb-2021 | Completed | Generating Revenue | |||
| 5. Seed Round | Completed | Startup | ||||
| 4. Accelerator/Incubator | Completed | Startup | ||||
| 3. Grant | 01-Jan-2016 | Completed | Startup | |||
| 2. Grant | 01-Jan-2014 | Completed | Startup | |||
| 1. Accelerator/Incubator | Completed | Startup |
Biomunex Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Biomunex Pharmaceuticals Comparisons
Industry
Financing
Details
Biomunex Pharmaceuticals Competitors (10)
One of Biomunex Pharmaceuticals’s 10 competitors is Volastra, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Savara | Formerly VC-backed | Yardley, PA |
Biomunex Pharmaceuticals Patents
Biomunex Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026180674-A1 | Antibodies specific to va7.2 domain of mucosal associated invariant t (mait) cells | Pending | 28-Feb-2025 | ||
| WO-2026068750-A1 | Antibodies that specifically bind mucosal associated invariant t (mait) cells | Pending | 27-Sep-2024 | ||
| AU-2023228330-A1 | Bispecific antibodies binding to her-3 and to either her-2 or egfr | Pending | 02-Mar-2022 | ||
| EP-4486774-A1 | Bispecific antibodies binding to her-3 and to either her-2 or egfr | Pending | 02-Mar-2022 | ||
| US-20250282892-A1 | Bispecific antibodies binding to her-3 and to either her-2 or egfr | Pending | 02-Mar-2022 | C07K16/32 |
Biomunex Pharmaceuticals Signals
Biomunex Pharmaceuticals Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Eurobail Formation | Corporation | Minority | ||
| French Government | Government | |||
| Onward Therapeutics | VC-Backed Company | Minority | ||
| L'Agence Nationale de la Recherche | Government | |||
| Bpifrance | Sovereign Wealth Fund |
Biomunex Pharmaceuticals FAQs
-
When was Biomunex Pharmaceuticals founded?
Biomunex Pharmaceuticals was founded in 2014.
-
Where is Biomunex Pharmaceuticals headquartered?
Biomunex Pharmaceuticals is headquartered in Paris, France.
-
What is the size of Biomunex Pharmaceuticals?
Biomunex Pharmaceuticals has 13 total employees.
-
What industry is Biomunex Pharmaceuticals in?
Biomunex Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Biomunex Pharmaceuticals a private or public company?
Biomunex Pharmaceuticals is a Private company.
-
What is Biomunex Pharmaceuticals’s current revenue?
The current revenue for Biomunex Pharmaceuticals is .
-
How much funding has Biomunex Pharmaceuticals raised over time?
Biomunex Pharmaceuticals has raised $6.41M.
-
Who are Biomunex Pharmaceuticals’s investors?
Eurobail Formation, French Government, Onward Therapeutics, L'Agence Nationale de la Recherche, and Bpifrance are 5 of 6 investors who have invested in Biomunex Pharmaceuticals.
-
Who are Biomunex Pharmaceuticals’s competitors?
Volastra, Ona Therapeutics, Ability Pharma, Genentech, and Savara are some of the 10 competitors of Biomunex Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process